tradingkey.logo
tradingkey.logo
Search

Zhengye Biotechnology Holding Ltd

ZYBT
Add to Watchlist
0.952USD
+0.002+0.25%
Close 05/15, 16:00ETQuotes delayed by 15 min
28.31MMarket Cap
LossP/E TTM

Zhengye Biotechnology Holding Ltd

0.952
+0.002+0.25%

More Details of Zhengye Biotechnology Holding Ltd Company

Zhengye Biotechnology Holding Ltd is a company mainly engaged in the research, development, manufacturing and sales of veterinary vaccines, with an emphasis on vaccines for livestock. The Company markets a diverse range of vaccines, including vaccines for swine, cattle, goats, sheep, poultry, and dogs. The Company owns about 44 veterinary vaccines in its product portfolio, which cover veterinary vaccines for livestock, including monovalent vaccine, polyvalent vaccine, combined vaccine and combined and polyvalent vaccine. The Company also engages in vaccines for treating livestock. The Company mainly conducts its business in the domestic market. The Company mainly conducts its business in the domestic and overseas market.

Zhengye Biotechnology Holding Ltd Info

Ticker SymbolZYBT
Company nameZhengye Biotechnology Holding Ltd
IPO dateJan 07, 2025
CEOHan (Aiden)
Number of employees277
Security typeOrdinary Share
Fiscal year-endJan 07
AddressNo.1 Lianmeng Street, Jilin Economic &
CityJILIN
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryChina
Postal code132101
Phone
Websitehttps://www.jlzybio.com./
Ticker SymbolZYBT
IPO dateJan 07, 2025
CEOHan (Aiden)

Company Executives of Zhengye Biotechnology Holding Ltd

Name
Name/Position
Position
Shareholding
Change
Mr. Zhenfa Han
Mr. Zhenfa Han
Chairman of the Board
Chairman of the Board
2.96M
--
Mr. Wei Lian
Mr. Wei Lian
Vice General Manager
Vice General Manager
83.06K
--
Mr. Yuyou He
Mr. Yuyou He
Vice General Manager
Vice General Manager
50.06K
--
Mr. Songlin Song
Mr. Songlin Song
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Mrs. Wenhua Sun
Mrs. Wenhua Sun
Director
Director
--
--
Mr. Ping Wang
Mr. Ping Wang
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Zhongyao Liu
Mr. Zhongyao Liu
Chief Operating Officer, Chief Compliance Officer
Chief Operating Officer, Chief Compliance Officer
--
--
Ms. Yuhong Cheng
Ms. Yuhong Cheng
Vice General Manager
Vice General Manager
--
--
Mr. Ping Jiang
Mr. Ping Jiang
Independent Director
Independent Director
--
--
Mr. Wenbing (Christopher) Wang
Mr. Wenbing (Christopher) Wang
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Zhenfa Han
Mr. Zhenfa Han
Chairman of the Board
Chairman of the Board
2.96M
--
Mr. Wei Lian
Mr. Wei Lian
Vice General Manager
Vice General Manager
83.06K
--
Mr. Yuyou He
Mr. Yuyou He
Vice General Manager
Vice General Manager
50.06K
--
Mr. Songlin Song
Mr. Songlin Song
Co-Chief Executive Officer
Co-Chief Executive Officer
--
--
Mrs. Wenhua Sun
Mrs. Wenhua Sun
Director
Director
--
--
Mr. Ping Wang
Mr. Ping Wang
Chief Financial Officer
Chief Financial Officer
--
--

Revenue Breakdown

Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2024
By BusinessUSD
Name
Revenue
Proportion
Swine vaccines
157.79M
84.67%
Poultry vaccines
15.51M
8.32%
Other vaccines
13.06M
7.01%
By RegionUSD
Name
Revenue
Proportion
China (Mainland)
186.36M
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Swine vaccines
157.79M
84.67%
Poultry vaccines
15.51M
8.32%
Other vaccines
13.06M
7.01%

Shareholding Stats

Updated: Thu, Feb 12
Updated: Thu, Feb 12
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Han (Zhenfa)
27.03%
Dong (Yawen)
1.14%
Lian (Wei)
0.76%
XTX Markets LLC
0.54%
He (Yuyou)
0.46%
Other
70.08%
Shareholders
Shareholders
Proportion
Han (Zhenfa)
27.03%
Dong (Yawen)
1.14%
Lian (Wei)
0.76%
XTX Markets LLC
0.54%
He (Yuyou)
0.46%
Other
70.08%
Shareholder Types
Shareholders
Proportion
Individual Investor
29.38%
Investment Advisor/Hedge Fund
0.84%
Venture Capital
0.54%
Investment Advisor
0.39%
Hedge Fund
0.30%
Research Firm
0.02%
Other
68.53%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
14
158.74K
0.89%
--
2026Q1
15
229.61K
2.09%
-128.24K
2025Q4
14
163.53K
0.35%
-106.83K
2025Q3
9
420.54K
0.89%
+410.76K
2025Q2
10
43.29M
91.34%
+40.32M
2025Q1
9
43.23M
91.66%
+40.26M
2024Q4
1
2.96M
6.28%
+2.96M

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Han (Zhenfa)
2.96M
6.25%
--
--
Jan 07, 2025
Dong (Yawen)
124.59K
0.26%
+124.59K
--
Jan 07, 2025
Lian (Wei)
83.06K
0.18%
+83.06K
--
Jan 07, 2025
XTX Markets LLC
59.29K
0.13%
+24.70K
+71.40%
Dec 31, 2025
He (Yuyou)
50.06K
0.11%
+50.06K
--
Jan 07, 2025
Winton Capital Management Ltd.
63.30K
0.13%
+41.75K
+193.76%
Dec 31, 2025
Citadel Advisors LLC
30.58K
0.06%
+18.89K
+161.67%
Dec 31, 2025
Geode Capital Management, L.L.C.
29.07K
0.06%
--
--
Dec 31, 2025
UBS Financial Services, Inc.
9.12K
0.02%
+4.79K
+110.56%
Dec 31, 2025
Tower Research Capital LLC
2.21K
0%
-2.25K
-50.54%
Dec 31, 2025
View more

Related ETFs

Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Invesco Golden Dragon China ETF
0.05%
Invesco Golden Dragon China ETF
Proportion0.05%

Dividend

A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data

Stock Splits

Date
Ex-dividend Date
Type
Ratio
No Data
Date
Ex-dividend Date
Type
Ratio
No Data
KeyAI